Melanie Sena

Agilent Technologies opens multimillion dollar Spectroscopy Technology Innovation Center in Australia.

Sangamo BioSciences has agreed to acquire Ceregene, a privately held biotechnology company focused on developing adeno-associated virus gene therapies.

AstraZeneca's MedImmune has agreed to acquire Amplimmune, which specializes in cancer immunology.

Amgen acquires Onyx Pharmaceuticals for $125 per share in cash.

Amgen, Servier collaborate ivabraline and other cardiovascular products.

New NIH policy requires researchers to apply for access to the full genome sequence data from HeLa cells.

iQur and the Edward Jenner Institute for Vaccine Research announced that that they will receive a grant of 152,000 EUR ($201,523) from the Technology Strategy Board's Biocatalyst fund to develop a novel malaria vaccine.

Designation granted by FDA for the treatment of trigeminal neuralgia.

Pfizer has announced plans to internally separate its commercial operations into three business segments.

A new method of vaccine design, called the Multiple Antigen Presentation System (MAPS), may result in vaccines that bring together the benefits of whole-cell and acellular or defined subunit vaccination.